Many tumors produce platelet-derived growth factor (PDGF)-DD, which promotes cellular proliferation, epithelial-mesenchymal transition, stromal reaction, and angiogenesis through autocrine and paracrine PDGFRβ signaling. By screening a secretome library, we found that the human immunoreceptor NKp44, encoded by NCR2 and expressed on natural killer (NK) cells and innate lymphoid cells, recognizes PDGF-DD. PDGF-DD engagement of NKp44 triggered NK cell secretion of interferon gamma (IFN)-γ and tumor necrosis factor alpha (TNF-α) that induced tumor cell growth arrest. A distinctive transcriptional signature of PDGF-DD-induced cytokines and the downregulation of tumor cell-cycle genes correlated with NCR2 expression and greater survival in glioblastoma. NKp44 expression in mouse NK cells controlled the dissemination of tumors expressing PDGF-DD more effectively than control mice, an effect enhanced by blockade of the inhibitory receptor CD96 or CpG-oligonucleotide treatment. Thus, while cancer cell production of PDGF-DD supports tumor growth and stromal reaction, it concomitantly activates innate immune responses to tumor expansion.
Pubmed ID: 29275861 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
Software environment and programming language for statistical computing and graphics. R is integrated suite of software facilities for data manipulation, calculation and graphical display. Can be extended via packages. Some packages are supplied with the R distribution and more are available through CRAN family.It compiles and runs on wide variety of UNIX platforms, Windows and MacOS.
View all literature mentionsProject exploring the spectrum of genomic changes involved in more than 20 types of human cancer that provides a platform for researchers to search, download, and analyze data sets generated. As a pilot project it confirmed that an atlas of changes could be created for specific cancer types. It also showed that a national network of research and technology teams working on distinct but related projects could pool the results of their efforts, create an economy of scale and develop an infrastructure for making the data publicly accessible. Its success committed resources to collect and characterize more than 20 additional tumor types. Components of the TCGA Research Network: * Biospecimen Core Resource (BCR); Tissue samples are carefully cataloged, processed, checked for quality and stored, complete with important medical information about the patient. * Genome Characterization Centers (GCCs); Several technologies will be used to analyze genomic changes involved in cancer. The genomic changes that are identified will be further studied by the Genome Sequencing Centers. * Genome Sequencing Centers (GSCs); High-throughput Genome Sequencing Centers will identify the changes in DNA sequences that are associated with specific types of cancer. * Proteome Characterization Centers (PCCs); The centers, a component of NCI's Clinical Proteomic Tumor Analysis Consortium, will ascertain and analyze the total proteomic content of a subset of TCGA samples. * Data Coordinating Center (DCC); The information that is generated by TCGA will be centrally managed at the DCC and entered into the TCGA Data Portal and Cancer Genomics Hub as it becomes available. Centralization of data facilitates data transfer between the network and the research community, and makes data analysis more efficient. The DCC manages the TCGA Data Portal. * Cancer Genomics Hub (CGHub); Lower level sequence data will be deposited into a secure repository. This database stores cancer genome sequences and alignments. * Genome Data Analysis Centers (GDACs) - Immense amounts of data from array and second-generation sequencing technologies must be integrated across thousands of samples. These centers will provide novel informatics tools to the entire research community to facilitate broader use of TCGA data. TCGA is actively developing a network of collaborators who are able to provide samples that are collected retrospectively (tissues that had already been collected and stored) or prospectively (tissues that will be collected in the future).
View all literature mentionsSoftware tool for versatile matrix visualization and analysis. Program to generate heatmaps from input data. JavaScript matrix visualization and analysis.
View all literature mentionsThis polyclonal secondary targets IgG2a
View all literature mentionsThis unknown targets IgG1
View all literature mentionsThis unknown targets Biotin
View all literature mentionsThis polyclonal targets rabbit IgG
View all literature mentionsThis polyclonal targets PDGFD
View all literature mentionsThis monoclonal targets p44/42 MAPK (Erk1/2)
View all literature mentionsThis polyclonal targets Erk1/2
View all literature mentionsThis polyclonal targets Phospho-FoxO3a (Ser253)
View all literature mentionsThis polyclonal targets Phospho-Akt (Ser473)
View all literature mentionsThis monoclonal targets ND
View all literature mentionsThis monoclonal targets CD140a
View all literature mentionsThis unknown targets HA
View all literature mentionsThis unknown targets Murine IgG2a Clone: MOPC-173
View all literature mentionsThis monoclonal targets Mouse IgG1 k Isotype Control
View all literature mentionsThis monoclonal targets Human PDGF-D MAb (Clone 680018)
View all literature mentionsThis monoclonal targets CD3 epsilon
View all literature mentionsThis monoclonal targets ROR gamma (t)
View all literature mentionsThis monoclonal targets CD5
View all literature mentionsThis monoclonal targets CD96
View all literature mentionsThis monoclonal targets CD279
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD3e
View all literature mentionsThis monoclonal targets NK1.1
View all literature mentionsThis monoclonal targets NK1.1
View all literature mentionsThis monoclonal targets NK1.1
View all literature mentionsThis monoclonal targets Gata-3
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD3e
View all literature mentionsThis monoclonal targets Mouse CCR6
View all literature mentionsThis monoclonal targets TNF
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis monoclonal targets CD107a (LAMP-1)
View all literature mentionsThis monoclonal targets IL-22
View all literature mentionsThis monoclonal targets TNF
View all literature mentionsThis monoclonal targets IFN gamma
View all literature mentionsThis monoclonal targets CD103
View all literature mentionsThis monoclonal targets CD196
View all literature mentionsThis monoclonal targets CD56
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD3 PerCP-Cy5.5 120 tests
View all literature mentionsThis monoclonal targets CD56 (NCAM)
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis unknown targets CD336
View all literature mentionsThis monoclonal targets CD336
View all literature mentionsThis unknown targets CD336
View all literature mentionsThis monoclonal targets CD112
View all literature mentionsThis monoclonal targets CD103 (Integrin αIEL chain)
View all literature mentionsThis monoclonal targets CD95
View all literature mentions